drugset / Trial / NCT01270971

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

NCT01270971

Phase 3 Completed 594 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Timeline

Start
2010-12-01
Primary completion
2012-11-30
Completion
2013-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tavaborole Small molecule 5 % Topical